Biblio

Found 358 results
[ Author(Desc)] Keyword Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
, a phase III trial of carboplatin and paclitaxel plus placebo versus carboplatin and paclitaxel plus concurrent bevacizumab followed by placebo, versus carboplatin and paclitaxel plus concurrent and extended bevacizumab, in women with newly diagnosied, pre, N Engl J Med, vol. 365, p. 2483, 2011.
, Bundy, B. N., Grendys, Jr., E. C., Benda, J. A., McMeekin, D. S., Sorosky, J., Miller, D. S., Eaton, L. A., Fiorica, J. V., and Study, G. Oncology G., Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study, J Clin Oncol, vol. 23, pp. 4626-33, 2005.
A
M. E. Abdel-Rahman, Butler, J., Sydes, M. R., Parmar, M. K. B., Gordon, E., Harper, P., Williams, C., Crook, A., Sandercock, J., Swart, A. Marie, Rachet, B., and Coleman, M. P., No socioeconomic inequalities in ovarian cancer survival within two randomised clinical trials, Br J Cancer, vol. 111, pp. 589-97, 2014.
J. Alexandre, Brown, C., Coeffic, D., Raban, N., Pfisterer, J., Maenpaa, J. U., Chalchal, H., Fitzharris, B., Volgger, B., Vergote, I. B., Pisano, C., Ferrero, A., and Pujade-Lauraine, E., CA-125 can be part of the tumour evaluation criteria in ovarian cancer trials: experience of the GCIG CALYPSO trial., Br J Cancer, vol. 106, no. 4, p. 637, 2012.
J. Alexandre, Ray-Coquard, I., Selle, F., Floquet, A., Cottu, P., Weber, B., Falandry, C., Lebrun, D., Pujade-Lauraine, E., and , Mucinous advanced epithelial ovarian carcinoma: clinical presentation and sensitivity to platinum-paclitaxel-based chemotherapy, the GINECO experience, Ann Oncol, vol. 21, pp. 2377-81, 2010.
D. G. Allen, Baak, J., Belpomme, D., Berek, J. S., Bertelsen, K., Huinink, W. W. ten Bok, van der Burg, M. E. L., Calvert, A. H., Conte, P. F., and Dauplat, J., Advanced epithelial ovarian cancer: 1993 consensus statements., Ann Oncol, vol. 4 Suppl 4, pp. 83-8, 1993.
F. Amant, Floquet, A., Friedlander, M. Leonard, Kristensen, G. B., Mahner, S., Nam, E. Ji, Powell, M. A., Ray-Coquard, I., Siddiqui, N. Ahmad, Sykes, P., Westermann, A. M., and Seddon, B., Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S67-72, 2014.
J. Ang, Gourley, C., Powell, C., High, H., Shapira-Frommer, R., Castonguay, V., De Greve, J., Atkinson, T., Yap, T. A., Sandhu, S., Banerjee, S., Chen, L., Friedlander, M. Leonard, Kaufman, B., Oza, A. M., Matulonis, U., Barber, L., Kozarewa, I., Fenwick, K., Assiotis, I., Campbell, J., Chen, L., de Bono, J., Gore, M. E., Lord, C., Ashworth, A., and Kaye, S. B., Efficacy of chemotherapy in BRCA1/2 mutation carrier ovarian cancer in the setting of PARP inhibitor resistance: a multi-institutional study, Clin Cancer Res, vol. 19, pp. 5485-93, 2013.
A. M. Angarita, Johnson, C. Alonia Lil, Fader, A. Nickles, and Christianson, M. S., Fertility preservation: A key survivorship issue for young women with cancer , Frontiers in Oncology , vol. 6, no. 102, 2016.
M. S. Anglesio, Carey, M. S., Köbel, M., Mackay, H., and Huntsman, D. G., Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010., Gynecol Oncol, vol. 121, no. 2, pp. 407-15, 2011.
D. ' T. Anna, Signorelli, M., Benedetti-Panici, P., Maggioni, A., Fossati, R., Fruscio, R., Milani, R., Bocciolone, L., Buda, A., Mangioni, C., Scambia, G., Angioli, R., Campagnutta, E., Grassi, R., and Landoni, F., Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial, Br J Cancer, vol. 107, pp. 785-92, 2012.
D. Armstrong, Bundy, B. N., Wenzel, L. B., Huang, H., Baergen, R., Lele, S., Copeland, L., Walker, J. L., Burger, R. A., and Group, G. Oncology, Intraperitoneal cisplatin and paclitaxel in ovarian cancer, N Engl J Med, vol. 354, pp. 34-43, 2006.
H. C. Kitchener, Swart, A. Marie, Qian, Q., Amos, C., and Parmar, M. K. B., Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study., Lancet, vol. 373, no. 9658, pp. 125-36, 2009.
P. Blake, Swart, A. Marie, Orton, J., Kitchener, H. C., Whelan, T., Lukka, H., Eisenhauer, E., Bacon, M., Tu, D., Parmar, M. K. B., Amos, C., Murray, C., and Qian, W., Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis., Lancet, vol. 373, no. 9658, pp. 137-46, 2009.
B
M. Bacon, Kitchener, H. C., Stuart, G. C. E., and Vermorken, J. B., The global impact of the Gynecologic Cancer InterGroup in enhancing clinical trials in ovarian cancer., Int J Gynecol Cancer, vol. 21, no. 4, pp. 746-9, 2011.
M. Bagnoli, Shi, T. Yan, Gourley, C., Speiser, P., Reuss, A., Nijman, H. W., Creutzberg, C. L., Scholl, S., Negrouk, A., Brady, M. F., Hasegawa, K., Oda, K., McNeish, I. A., Kohn, E. C., Oza, A. M., MacKay, H., Millan, D., Bennett, K., Scott, C., and Mezzanzanica, D., Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions., Cells, vol. 8, no. 3, 2019.
S. Banerjee, Rustin, G. J. S., Paul, J., Williams, C., Pledge, S., Gabra, H., Skailes, G., Lamont, A., Hindley, A., Goss, G., Gilby, E., Hogg, M., Harper, P., Kipps, E., Lewsley, L. A., Hall, M., Vasey, P. A., and Kaye, S. B., A multicenter, randomized trial of flat dosing versus intrapatient dose escalation of single-agent carboplatin as first-line chemotherapy for advanced ovarian cancer: an SGCTG (SCOTROC 4) and ANZGOG study on behalf of GCIG., Ann Oncol, vol. 24, no. 3, p. 687, 2013.
R. R. Barakat, Bundy, B. N., Spirtos, N. M., Bell, J. G., Mannel, R., and Study, G. Oncology G., Randomized double-blind trial of estrogen replacement therapy versus placebo in stage I or II endometrial cancer: a Gynecologic Oncology Group Study, J Clin Oncol, vol. 24, pp. 587-92, 2006.
S. V. Barrett, Paul, J., Hay, A., Vasey, P. A., Kaye, S. B., Glasspool, R. M., and Group, S. Gynaecolog, Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial, Ann Oncol, vol. 19, pp. 898-902, 2008.
J. G. Bell, Brady, M. F., Young, R. C., Lage, J., Walker, J. L., Look, K. Y., Rose, G. S., Spirtos, N. M., and Group, G. Oncology, Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: a Gynecologic Oncology Group study, Gynecol Oncol, vol. 102, pp. 432-9, 2006.
J. S. Berek, Bertelsen, K., du Bois, A., Brady, M. F., Carmichael, J., Eisenhauer, E., Gore, M. E., Grenman, S., Hamilton, T. C., Hansen, S. W., Harper, P. G., Horvath, G., Kaye, S. B., Lück, H. J., Lund, B., McGuire, W. P., Neijt, J. P., Ozols, R. F., Parmar, M. K. B., Piccart, M. J., van Rijswijk, R., Rosenberg, P., Rustin, G. J. S., Sessa, C., and Willemse, P. H., Advanced epithelial ovarian cancer: 1998 consensus statements., Ann Oncol, vol. 10 Suppl 1, pp. 87-92, 1999.
J. S. Berek, Bertelsen, K., du Bois, A., Brady, M. F., Carmichael, J., Eisenhauer, E., Gore, M. E., Grenman, S., Hamilton, T. C., Hansen, S. W., Harper, P. G., Horvath, G., Kaye, S. B., Lück, H. J., Lund, B., McGuire, W. P., Neijt, J. P., Ozols, R. F., Parmar, M. K. B., Piccart, M. J., van Rijswijk, R., Rosenberg, P., Rustin, G. J. S., Sessa, C., Thigpen, J. T., Tropé, C. G., Tuxen, M. K., Vergote, I. B., Vermorken, J. B., and Willemse, P. H., [Epithelial ovarian cancer (advanced stage): consensus conference (1998)]., Gynecol Obstet Fertil, vol. 28, no. 7-8, pp. 576-83, 2000.
K. Bertelsen, Grenman, S., and Rustin, G. J. S., How long should first-line chemotherapy continue?, Ann Oncol, vol. 10 Suppl 1, pp. 17-20, 1999.
D. Berton-Rigaud, Devouassoux-Shisheboran, M., Ledermann, J. A., Leitao, M. M., Powell, M. A., Poveda, A. M., Beale, P., Glasspool, R. M., Creutzberg, C. L., Harter, P., Kim, J. - W., Reed, N. Simon, and Ray-Coquard, I., Gynecologic Cancer InterGroup (GCIG) consensus review for uterine and ovarian carcinosarcoma., Int J Gynecol Cancer, vol. 24, no. 9 Suppl 3, pp. S55-60, 2014.

Pages

Modify or remove your filters and try again.